Advertisement

Topics

Kamada ltd Company Profile

06:00 EST 18th December 2018 | BioPortfolio

Kamada is a biopharmaceutical company engaged in development, production and marketing of specialty plasma therapeutics, specific and general immune globulins and other prescribed medicines using sophisticated chromatographic purification technology.
Kamada's manufacturing facility holds latest and most advanced equipment for production of high-quality products. The fully computerized facility keeps Kamada at the cutting edge in maintenance of the highest standards of quality and safety for its products.

While operating in a surrounding that has recently become more demanding for higher safety and quality levels, greater product availability and at the same time maintaining competitive price level s , Kamada is being able to provide the necessary solutions for all of the above requirements by delivering virally inactivated, highly pure products sourced out of top-quality, US- FDA approved, plasma sources while retain ing profitability thanks to its efficient production process.


News Articles [16 Associated News Articles listed on BioPortfolio]

Kamada Reports Financial Results for Third Quarter and First Nine Months of 2018

Total Revenues for First Nine Months of 2018 were $66.3 Million, a 1% Decrease Year-Over-YearGross Profit for First Nine Months of 2018 was $20.2 million, a  1% Decrease Year-Over-Year Adjusted EBIT...

Kamada Provides Updated Full-Year 2018 Revenue Guidance

As result of the recent labor strike part of 2018 shipments are likely to be delayed to early 2019 Subsequent update and full-year 2019 revenue guidance to be provided later this year REHOVOT,...

Kamada Reports Financial Results for Second Quarter and First Six Months of 2018

Total Revenues for Second Quarter were $33.8 Million, a 4% Increase Over Second Quarter of 2017Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017Gross Pr...

Kamada Ltd. (KMDA) CEO Amir London on Q3 2018 Results - Earnings Call Transcript

Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference

REHOVOT, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company, announced today that Amir London, Chief Executive Officer, wi...

Your Daily Pharma Scoop: Kamada Phase 3 Approved, Vivus Positive, IsoRay Down

Kamada Announces the End of the Labor Strike in the Company’s Manufacturing Facility; All Employees Returned to Work

REHOVOT, Israel, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced that on August 15, 2018, the Company, the Emp...

Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT

REHOVOT, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that it has received positiv...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Glassia [Baxter Healthcare Corporation]

These highlights do not include all the information needed to use GLASSIA safely and effectively. See full prescribing information for GLASSIA.GLASSIA (Alpha-Proteinase Inhibitor (Human)) Injection So...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Synergetic Effects of Triplet-Triplet Annihilation and Directional Triplet Exciton Migration in Organic Crystal for Photon Up-Conversion.

In condensed solid, triplet exciton migration and succeeding triplet-triplet annihilation (TTA) are major bottleneck processes for efficient photon upconversion (UC) using sunlight excitation. We theo...

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Kamada

Kamada is a public biopharmaceutical company (TASE: KMDA) developing, producing and marketing a line of specialty life-saving biopharmaceuticals. Licensed and marketed worldwide, ...

Kamada, Ltd.

Kamada is a public biopharmaceutical company (TASE: KMDA) developing, producing and marketing a line of specialty life-saving biopharmaceuticals. Licensed and marketed worldwide, ...

Kamada LTD.

Kamada is a public biopharmaceutical company (TASE: KMDA) developing, producing and marketing a line of specialty, life-saving therapeutics using a sophisticated chromatographic p...

Kamada ltd

Kamada is a biopharmaceutical company engaged in development, production and marketing of specialty plasma therapeutics, specific and general immune globulins and other prescribed medicines using soph...

More Information about "Kamada ltd" on BioPortfolio

We have published hundreds of Kamada ltd news stories on BioPortfolio along with dozens of Kamada ltd Clinical Trials and PubMed Articles about Kamada ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kamada ltd Companies in our database. You can also find out about relevant Kamada ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record